Healthcare Pharmaceuticals Ltd.
Additional OffersShow all
Subcutaneous Active immunisation against varicella infection Adult: >12yr: 2 doses of 0.5 ml each. 2nd dose to be given at least 4 weeks later after t... View More
Subcutaneous Active immunisation against varicella infection Child: >12yr: 2 doses of 0.5 ml each. 2nd dose to be given at least 4 weeks later after t... View More
Hypersensitivity to neomycin, gelatin or other components of the vaccine. Malignant neoplasm of the bone marrow or lymphatic systems. Patients who are c... View More
Mode of Action
Live, attenuated varicella virus stimulates active immunity to disease caused by varicella-zoster virus. Conveys active immunity via stimulation of p... View More
Vaccination should be deferred for at least 5-11 mth following blood or plasma transfusion, or admin of immune globulin. Delay admin of vaccine for at l... View More
>10% Injection site swelling/rash/pruritus/erythema (20%) Fever >102°F [39°C] (15%) Potentially Fatal: Anaphylaxis, Stevens-Johnson syndrome.
Avoid use of salicylates for 6 wk after vaccination to reduce risk of Reye's syndrome. Decreased efficacy of vaccine with antiviral agents active agains... View More
Alternative brand for Varivax
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More